MENU

Can the Leverage Shares 2X Long CRM Daily ETF (CRMG) Reach $15?

Category: #Trading
CRMG
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
Sep 09, 2026

Can the Leverage Shares 2X Long CRM Daily ETF (CRMG) Reach $15?

Investors tracking single-stock leveraged exchange-traded funds (ETFs) have increasingly asked whether CRMG can push toward $15 per share. The fund in question is the Leverage Shares 2X Long CRM Daily ETF, an actively managed, non-diversified ETF that seeks to deliver two times (200%) the daily percentage change of Salesforce, Inc. (CRM) stock, before fees and expenses. After a volatile stretch that took the fund from a 52-week low near $3.65 to a 52-week high around $14.48, shares have recently consolidated near the $10 level, making the $15 target a meaningful, widely discussed price objective.

Key Takeaways

  • Price target in focus: $15, roughly 50% above the recent price and just beyond the fund's 52-week high near $14.48.
  • Strongest bullish factor: CRMG is built to amplify Salesforce's daily gains, so any sustained rally in CRM could translate into an outsized move higher.
  • Biggest risk: Daily rebalancing and compounding can erode returns over time, even when the underlying stock trends higher.
  • Key levels: The $14.48 area is a major resistance zone, while recent lows near $3.65–$4 represent long-term support.
  • Bottom line: The target is reachable only if Salesforce stages a decisive, sustained advance; leverage cuts both ways.

What CRMG Is and Why $15 Matters

CRMG is not a conventional diversified ETF. It holds a concentrated portfolio built primarily from swap agreements tied to Salesforce, along with U.S. Treasury obligations used as collateral. Its mandate is deliberately narrow: provide leveraged daily exposure to a single company. As a result, the fund's fate is almost entirely dictated by how CRM performs each trading day, magnified roughly two-to-one.

Because the fund carries a net expense ratio around 0.78% and is designed for short-term tactical trading rather than buy-and-hold investing, its price history is exceptionally volatile. The fund's 52-week range of roughly $3.65 to $14.48 underscores that scale of movement. Against that backdrop, $15 represents a psychologically clean round number that sits just above the prior peak, making it a natural focal point for traders asking whether the rebound can extend into new highs.

The Leverage Factor: A Double-Edged Sword

The single most important variable in the "Can CRMG reach $15?" question is the mechanics of daily leveraged returns. Because the fund resets its 2x exposure every day, its longer-horizon return does not simply equal two times Salesforce's return. In choppy markets, a phenomenon known as volatility drag can cause the ETF to lag or decay relative to a simple multiple of the underlying stock, even if CRM finishes the period higher.

This cuts both ways. In a strong, persistent uptrend for Salesforce, compounding can work in the fund's favor and produce gains that exceed a static 2x figure over time. But in a sideways or whipsawing market, the same math works against holders. For CRMG to reach $15, the more favorable scenario would likely need to play out: a sustained, directional rally in CRM rather than merely a series of alternating up and down days.

What Could Drive a Move Toward $15

The primary catalyst is straightforward: Salesforce itself. As a leading provider of cloud-based customer relationship management software, Salesforce has leaned heavily into artificial intelligence through its "Agentforce" platform, positioning enterprise software demand and AI adoption as key themes for its share price. Strong quarterly results, rising subscription revenue, or renewed enthusiasm around AI monetization could each spark the kind of multi-week advance that leveraged products amplify.

Technical momentum also matters. Having recovered sharply from its mid-2026 lows near $4, CRMG has already demonstrated how quickly leveraged ETFs can reprice when the underlying stock trends higher. A decisive break above the $14.48 resistance zone, backed by continued CRM strength, would open the path toward the $15 level and potentially beyond.

Obstacles and Risks

The most significant obstacle is concentration risk. CRMG's entire performance hinges on a single company, leaving no diversification to cushion a Salesforce-specific setback. A disappointing earnings report, a slowdown in enterprise software spending, or broader weakness in technology equities could trigger a leveraged decline just as quickly as positive news fuels a rally.

Leverage decay is a second persistent headwind. Even for investors who are correct about Salesforce's eventual direction, the daily reset mechanism can reduce realized returns during volatile periods. The fund's 0.78% expense ratio also compounds the cost of holding a product explicitly designed for short-term use. Together, these factors mean the path to $15 is unlikely to be a straight line.

Technical Levels That Matter

On the upside, the $14.48 area stands out as the critical resistance zone, since it marks the fund's recent peak and the last hurdle before $15. A move through that level on strong underlying momentum would put the round-number target within reach. On the downside, the mid-single-digit range around $7 and the low-$4 region represent meaningful support areas where buyers have previously stepped in. How CRMG behaves around these zones will be a key signal for traders assessing whether the rally has staying power.

AI Daily Buy/Sell Signals

Traders monitoring fast-moving, high-volatility instruments like CRMG often benefit from tools that track shifting conditions in real time. Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market behavior, technical patterns, and AI-driven analysis. These signals can help traders spot emerging opportunities, monitor existing positions, and identify shifts in market trends more efficiently than manual screening alone. For those watching whether CRMG can build momentum toward its next resistance level, such tools offer a way to stay aligned with evolving market conditions.

Final Assessment

Reaching $15 appears possible but far from assured. The strongest case rests on Salesforce sustaining a directional rally that CRMG's 2x structure would amplify, with a break above $14.48 serving as the clearest technical confirmation. Against that, concentration risk, volatility drag, and the fund's short-term design present real obstacles that could prevent the move or make the journey highly uneven. Investors should monitor Salesforce's earnings and AI-related developments, CRMG's behavior at the $14.48 resistance zone, and overall technology-sector momentum. As with any leveraged product, the outcome depends more on the path the underlying stock takes than on the destination itself.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
CRMG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CRMG and ETFs

Correlation & Price change

A.I.dvisor tells us that CRMG and TQQQ have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRMG and TQQQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRMG
1D Price
Change %
CRMG100%
+3.70%
TQQQ - CRMG
9%
Poorly correlated
+2.56%
SSO - CRMG
4%
Poorly correlated
+1.65%
SPXL - CRMG
4%
Poorly correlated
+2.43%
QLD - CRMG
3%
Poorly correlated
+1.74%
SOXL - CRMG
0%
Poorly correlated
+5.23%